サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1450977

次世代シーケンシング（NGS）市場レポート：シーケンスタイプ、製品タイプ、技術、用途、エンドユーザー、地域別、2024-2032

Next-Generation Sequencing Market Report by Sequencing Type, Product Type, Technology, Application, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
次世代シーケンシング（NGS）市場レポート：シーケンスタイプ、製品タイプ、技術、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

次世代シーケンシング（NGS）の世界市場規模は2023年に201億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて16.2%の成長率（CAGR）を示し、2032年までに804億米ドルに達すると予測しています。

次世代シーケンシング（NGS）は、デオキシリボ核酸（DNA）の一部分のヌクレオチドの配列を決定する並列シーケンシング技術です。合成によるシーケンシング（SBS）やイオン半導体、1分子リアルタイム（SMRT）、ナノポアシーケンシングなど、さまざまな手順が含まれます。これは、医療専門家が高い精度とスピードで正確な結果を得られるよう支援する、費用対効果の高いソリューションです。また、臨床診断、個別化医療、遺伝子医療、農業や動物研究の分野での調査も促進します。現在では、ドラッグデリバリーのプロセスをエスカレートさせるために、薬理ゲノミクスで活用されています。

次世代シーケンシング（NGS）の市場動向：

世界の老人人口の増加と、がん、心血管疾患、神経疾患などのさまざまな慢性疾患の有病率の上昇は、市場にプラスの影響を与える主な要因の1つです。また、病状の原因となる遺伝子を分析するために、科学者を導く遺伝子地図の利用が増加していることも要因のひとつです。さらに、がん診断におけるリキッドバイオプシーの広範な採用や、リアルタイムのがんモニタリングと検出のための非侵襲的がんバイオマーカーを導入するためのNGS技術の利用の増加が、市場の前向きな見通しを生み出しています。これに伴い、データのセキュリティと管理を強化するためのクラウドコンピューティングシステムの統合など、シーケンサーにおける継続的な技術革新が市場の成長を強化しています。これとは別に、ヘルスケア・インフラを改善するための各国政府による継続的な資金調達が、市場の成長を後押ししています。さらに、大手企業による分子生物学、技術工学、シーケンシング化学の研究開発（R&D）活動への投資の増加が、良好な市場見通しをもたらしています。

本レポートで扱う主な質問

  • 2023年の次世代シーケンシング（NGS）の世界市場規模は？
  • 2024年から2032年にかけての次世代シーケンシング（NGS）の世界市場の予想成長率は？
  • 次世代シーケンシング（NGS）の世界市場を牽引する主要因は何ですか？
  • COVID-19が次世代シーケンシング（NGS）の世界市場に与えた影響は？
  • シーケンシングタイプ別次世代シーケンシング（NGS）の世界市場の内訳は？
  • 製品タイプ別次世代シーケンシング（NGS）の世界市場の内訳は？
  • 技術別次世代シーケンシング（NGS）の世界市場の内訳は？
  • 次世代シーケンシング（NGS）の世界市場の用途別区分は？
  • エンドユーザー別次世代シーケンシング（NGS）の世界市場の内訳は？
  • 次世代シーケンシング（NGS）の世界市場における主要地域は？
  • 次世代シーケンシング（NGS）の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 次世代シーケンシング（NGS）の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：シーケンシングタイプ別

  • 全ゲノムシーケンシング
    • 市場動向
    • 市場予測
  • ターゲットリシーケンシング
    • 市場動向
    • 市場予測
  • ホールエクソームシーケンシング
    • 市場動向
    • 市場予測
  • RNAシーケンシング
    • 市場動向
    • 市場予測
  • CHIPシーケンシング
    • 市場動向
    • 市場予測
  • デノボシーケンシング
    • 市場動向
    • 市場予測
  • メチルシーケンシング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：製品タイプ別

  • 機器
    • 市場動向
    • 市場予測
  • 試薬・消耗品
    • 市場動向
    • 市場予測
  • ソフトウェアとサービス
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • シーケンシング：合成別
    • 市場動向
    • 市場予測
  • イオン半導体シーケンシング
    • 市場動向
    • 市場予測
  • 1分子リアルタイムシーケンシング
    • 市場動向
    • 市場予測
  • ナノポアシーケンシング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • バイオマーカー・がん
    • 市場動向
    • 市場予測
  • 創薬と個別化医療
    • 市場動向
    • 市場予測
  • 遺伝子スクリーニング
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • 農業と動物研究
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 学術機関・研究センター
    • 市場動向
    • 市場予測
  • 病院・クリニック
    • 市場動向
    • 市場予測
  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格指標

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • 10x Genomics
    • BGI Group
    • Eurofins Scientific
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Genewiz
    • Macrogen Inc.
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Genapsys Inc.
図表

List of Figures

  • Figure 1: Global: Next-Generation Sequencing Market: Major Drivers and Challenges
  • Figure 2: Global: Next-Generation Sequencing Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Next-Generation Sequencing Market: Breakup by Sequencing Type (in %), 2023
  • Figure 4: Global: Next-Generation Sequencing Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Next-Generation Sequencing Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Next-Generation Sequencing Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Next-Generation Sequencing Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Next-Generation Sequencing Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Next-Generation Sequencing Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Next-Generation Sequencing (Whole Genome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Next-Generation Sequencing (Targeted Resequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Next-Generation Sequencing (Targeted Resequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Next-Generation Sequencing (Whole Exome Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Next-Generation Sequencing (RNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Next-Generation Sequencing (RNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Next-Generation Sequencing (CHIP Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Next-Generation Sequencing (CHIP Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Next-Generation Sequencing (De Novo Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Next-Generation Sequencing (De Novo Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Next-Generation Sequencing (Methyl Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Next-Generation Sequencing (Methyl Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Next-Generation Sequencing (Other Sequencing Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Next-Generation Sequencing (Other Sequencing Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Next-Generation Sequencing (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Next-Generation Sequencing (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Next-Generation Sequencing (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Next-Generation Sequencing (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Next-Generation Sequencing (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Next-Generation Sequencing (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Next-Generation Sequencing (Sequencing by Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Next-Generation Sequencing (Ion Semiconductor Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Next-Generation Sequencing (Single-Molecule Real-Time Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Next-Generation Sequencing (Nanopore Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Next-Generation Sequencing (Nanopore Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Next-Generation Sequencing (Biomarker and Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Next-Generation Sequencing (Biomarker and Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Next-Generation Sequencing (Drug Discovery and Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Next-Generation Sequencing (Genetic Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Next-Generation Sequencing (Genetic Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Next-Generation Sequencing (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Next-Generation Sequencing (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: Next-Generation Sequencing (Agriculture and Animal Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Global: Next-Generation Sequencing (Academic Institutes & Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Global: Next-Generation Sequencing (Hospitals & Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Global: Next-Generation Sequencing (Hospitals & Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Global: Next-Generation Sequencing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Global: Next-Generation Sequencing (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Global: Next-Generation Sequencing (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: North America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: North America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United States: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United States: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Canada: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Canada: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Asia Pacific: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Asia Pacific: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: China: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: China: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Japan: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Japan: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: India: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: India: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: South Korea: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: South Korea: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Australia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Australia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Indonesia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Indonesia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Europe: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Europe: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Germany: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Germany: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: France: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: France: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: United Kingdom: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: United Kingdom: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Italy: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Italy: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Spain: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Spain: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Russia: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Russia: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Latin America: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Latin America: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 102: Brazil: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 103: Brazil: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Mexico: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 105: Mexico: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 106: Others: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 107: Others: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 108: Middle East and Africa: Next-Generation Sequencing Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 109: Middle East and Africa: Next-Generation Sequencing Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 110: Global: Next-Generation Sequencing Industry: SWOT Analysis
  • Figure 111: Global: Next-Generation Sequencing Industry: Value Chain Analysis
  • Figure 112: Global: Next-Generation Sequencing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next-Generation Sequencing Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Next-Generation Sequencing Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Next-Generation Sequencing Market Forecast: Breakup by Sequencing Type (in Million US$), 2024-2032
  • Table 4: Global: Next-Generation Sequencing Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Next-Generation Sequencing Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Next-Generation Sequencing Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Next-Generation Sequencing Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Next-Generation Sequencing Market Structure
  • Table 9: Global: Next-Generation Sequencing Market: Key Players
目次
Product Code: SR112024A2039

The global next-generation sequencing (NGS) market size reached US$ 20.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 80.4 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032.

Next-generation sequencing (NGS) is a parallel sequencing technology that determines the sequence of nucleotides in a section of the deoxyribonucleic acid (DNA). It involves various procedures, such as sequencing by synthesis (SBS) and ion semiconductor, single-molecule real-time (SMRT), and nanopore sequencing. It is a cost-effective solution that assists medical professionals in achieving precise results with high accuracy and speed. It also facilitates research in the fields of clinical diagnostics, personalized and genetic medicines, and agriculture and animal studies. At present, it is utilized in pharmacogenomics to escalate the drug delivery process.

Next-Generation Sequencing (NGS) Market Trends:

The growing global geriatric population and the rising prevalence of various chronic medical disorders, such as cancer, cardiovascular, and neurological disorders, represent one of the key factors positively influencing the market. It can also be attributed to the growing use of genetic maps for guiding scientists to analyze the genes that are responsible for medical conditions. In addition, the widespread adoption of liquid biopsies in cancer diagnostics and the increasing utilization of NGS technologies to introduce non-invasive cancer biomarkers for real-time cancer monitoring and detection are creating a positive market outlook. In line with this, continuous technological innovations in sequencers, such as the integration of cloud-computing systems for enhanced data security and management, are strengthening the market growth. Apart from this, continuous financing by governments of various countries to improve healthcare infrastructure is providing a thrust to the market growth. Furthermore, increasing investments by leading players in research and development (R&D) activities for molecular biology, technical engineering, and sequencing chemistry is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global next-generation sequencing (NGS) market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on sequencing type, product type, technology, application and end-user.

Breakup by Sequencing Type:

Whole Genome Sequencing

Targeted Resequencing

Whole Exome Sequencing

RNA Sequencing

CHIP Sequencing

De Novo Sequencing

Methyl Sequencing

Others

Targeted resequencing represents the largest market segment due to the presence of numerous companies in the NGS market offering targeted resequencing services.

Breakup by Product Type:

Instruments

Reagents and Consumables

Software and Services

Reagents and consumables represent the most commonly used product type that assists in sample preparation, DNA isolation, sample cleanup, target enrichment, and quality assurance.

Breakup by Technology:

Sequencing by Synthesis

Ion Semiconductor Sequencing

Single-Molecule Real-Time Sequencing

Nanopore Sequencing

Others

Sequencing by synthesis finds extensive applications on account of its high accuracy in performing DNA sequencing and its growing incorporation in NGS instrumentation. In addition, it offers the highest yield of error-free throughput results.

Breakup by Application:

Biomarker and Cancer

Drug Discovery and Personalized Medicine

Genetic Screening

Diagnostics

Agriculture and Animal Research

Others

Biomarker and cancer currently dominate the market due to the rising prevalence of cancer and increasing awareness among individuals about the benefits of early diagnosis and treatment.

Breakup by End-User:

Academic Institutes & Research Centers

Hospitals & Clinics

Pharmaceutical & Biotechnology Companies

Others

Academic institutes and research centers account for the majority of the market share due to the increasing application of NGS solutions in research projects.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market due to the availability of a technologically advanced healthcare research framework in the region, coupled with the presence of multiple clinical laboratories that employ NGS to provide genetic testing services.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc., etc.

Key Questions Answered in This Report

  • 1. What was the size of the global next-generation sequencing (NGS) market in 2023?
  • 2. What is the expected growth rate of the global next-generation sequencing (NGS) market during 2024-2032?
  • 3. What are the key factors driving the global next-generation sequencing (NGS) market?
  • 4. What has been the impact of COVID-19 on the global next-generation sequencing (NGS) market?
  • 5. What is the breakup of the global next-generation sequencing (NGS) market based on the sequencing type?
  • 6. What is the breakup of the global next-generation sequencing (NGS) market based on the product type?
  • 7. What is the breakup of the global next-generation sequencing (NGS) market based on the technology?
  • 8. What is the breakup of the global next-generation sequencing (NGS) market based on the application?
  • 9. What is the breakup of the global next-generation sequencing (NGS) market based on the end- user?
  • 10. What are the key regions in the global next-generation sequencing (NGS) market?
  • 11. Who are the key players/companies in the global next-generation sequencing (NGS) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next-Generation Sequencing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Sequencing Type

  • 6.1 Whole Genome Sequencing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Targeted Resequencing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Whole Exome Sequencing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 RNA Sequencing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CHIP Sequencing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 De Novo Sequencing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Methyl Sequencing
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents and Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Software and Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing by Synthesis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ion Semiconductor Sequencing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Single-Molecule Real-Time Sequencing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nanopore Sequencing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomarker and Cancer
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Discovery and Personalized Medicine
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Genetic Screening
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Diagnostics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Agriculture and Animal Research
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Academic Institutes & Research Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals & Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical & Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 10x Genomics
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 BGI Group
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Eurofins Scientific
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche AG
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Genewiz
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Macrogen Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 Oxford Nanopore Technologies
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Pacific Biosciences
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Perkinelmer Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis
    • 16.3.14 Qiagen N.V.
      • 16.3.14.1 Company Overview
      • 16.3.14.2 Product Portfolio
      • 16.3.14.3 Financials
      • 16.3.14.4 SWOT Analysis
    • 16.3.15 Genapsys Inc.
      • 16.3.15.1 Company Overview
      • 16.3.15.2 Product Portfolio